Zaburzenie schizoafektywne – Rokowania, prognozy i postęp choroby

Zaburzenie schizoafektywne
Rokowania, prognozy i postęp choroby

Zaburzenie schizoafektywne charakteryzuje się rokowaniem pośrednim pomiędzy schizofrenią a zaburzeniami afektywnymi, z funkcjonowaniem pacjentów lepszym niż w schizofrenii, ale gorszym niż w chorobie afektywnej dwubiegunowej i depresji jednobiegunowej. Wieloletnie badania podłużne wskazują, że w okresie 10 lat pacjenci z zaburzeniem schizoafektywnym osiągają lepsze wyniki leczenia niż osoby ze schizofrenią, jednak gorsze niż pacjenci z psychotycznymi zaburzeniami afektywnymi. Kluczowymi czynnikami negatywnie wpływającymi na rokowanie są objawy psychotyczne niezgodne z nastrojem (P≤0,05), zła historia przedchorobowa, podstępny początek, dominująca psychoza, objawy negatywne, wczesny początek, nieustępujący przebieg oraz obciążenie rodzinne schizofrenią. Podtyp dwubiegunowy zaburzenia schizoafektywnego wiąże się z lepszym rokowaniem, zbliżonym do choroby afektywnej dwubiegunowej typu I, natomiast podtyp depresyjny ma rokowanie podobne do schizofrenii.

Prognostyka zaburzenia schizoafektywnego

Porównanie z innymi zaburzeniami psychotycznymi
Czynniki wpływające na rokowanie
Podtypy zaburzenia schizoafektywnego a rokowanie
Wskaźniki remisji i powrotu do zdrowia
Znaczenie leczenia dla rokowania
Nowe perspektywy w prognozowaniu zaburzenia schizoafektywnego

Wnioski końcowe

Kolejne rozdziały

Prognostyka zaburzenia schizoafektywnego

Zaburzenie schizoafektywne zajmuje szczególne miejsce w spektrum zaburzeń psychotycznych, a jego rokowanie jest przedmiotem licznych badań klinicznych. Aktualne dane wskazują, że rokowanie w zaburzeniu schizoafektywnym plasuje się pomiędzy rokowaniem w schizofrenii a zaburzeniami afektywnymi – jest lepsze niż w przypadku schizofrenii, ale gorsze niż w przypadku zaburzeń afektywnych.¹²³ Pacjenci z zaburzeniem schizoafektywnym wykazują funkcjonowanie nieco lepsze niż osoby ze schizofrenią, gorsze niż osoby z chorobą afektywną dwubiegunową i znacząco gorsze niż pacjenci z jednobiegunową depresją.⁴

Porównanie z innymi zaburzeniami psychotycznymi

Wieloletnie badania podłużne konsekwentnie wykazują, że ogólny wynik leczenia pacjentów z zaburzeniami schizoafektywnymi jest lepszy niż pacjentów ze schizofrenią, ale gorszy niż pacjentów z psychotycznymi zaburzeniami afektywnymi w ciągu 10-letniego okresu obserwacji.⁵ Analiza regresji logistycznej czterech grup diagnostycznych (schizofrenia, zaburzenia schizoafektywne, psychotyczne zaburzenia afektywne i depresja niepsychotyczna) najlepiej wyjaśniała wariancję w przyczynianiu się diagnozy do niekorzystnego wyniku (P≤0,01).⁶

We wszystkich czterech kontrolach w badaniach podłużnych mniej pacjentów z zaburzeniami schizoafektywnymi niż ze schizofrenią wykazywało jednorodnie złe rokowanie.⁷ Istotne jest również, że osoby z zaburzeniem schizoafektywnym mają większą szansę na powrót do poprzedniego poziomu funkcjonowania niż osoby z większością innych zaburzeń psychotycznych, chociaż długoterminowe leczenie jest często konieczne, a wyniki różnią się w zależności od pacjenta.⁸

Czynniki wpływające na rokowanie

Wśród kluczowych czynników wpływających na rokowanie w zaburzeniach schizoafektywnych szczególne znaczenie mają objawy psychotyczne niezgodne z nastrojem. Pacjenci z objawami psychotycznymi niezgodnymi z nastrojem podczas indeksowej hospitalizacji wykazywali znacznie gorsze późniejsze wyniki (P≤0,05).⁹ Obecne dane potwierdzają hipotezę, że pacjenci z przewagą objawów psychotycznych niezgodnych z nastrojem są bardziej narażeni na późniejsze trudności w innych obszarach funkcjonowania.¹⁰

Niekorzystne rokowanie u pacjentów z zaburzeniem schizoafektywnym jest ogólnie związane z:¹¹

Złą historią przedchorobową
Podstępnym początkiem zaburzenia
Brakiem czynników wyzwalających
Dominującą psychozą
Objawami negatywnymi
Wczesnym początkiem
Nieustępującym przebiegiem
Posiadaniem członka rodziny ze schizofrenią

Podtypy zaburzenia schizoafektywnego a rokowanie

Istnieją również różnice w rokowaniu w zależności od podtypu zaburzenia schizoafektywnego. Uważa się, że osoby z podtypem dwubiegunowym mają rokowanie podobne do osób z chorobą afektywną dwubiegunową typu I, natomiast rokowanie osób z podtypem depresyjnym jest uważane za podobne do rokowania osób ze schizofrenią.¹² Ta różnica podkreśla znaczenie dokładnej diagnozy podtypu dla planowania leczenia i prognozowania przebiegu choroby.

Wskaźniki remisji i powrotu do zdrowia

Badania długoterminowe wykazują, że odsetek pacjentów z zaburzeniem schizoafektywnym spełniających kryteria remisji klinicznej był co najmniej o dziesięć punktów procentowych wyższy niż obserwowany wśród pacjentów ze schizofrenią, niezależnie od przyjętych kryteriów remisji.¹³ W odniesieniu do wskaźników powrotu do zdrowia, podobnie wysoce istotna różnica (ponad 16 punktów procentowych) pojawiła się między pacjentami schizoafektywnymi a schizofrenicznymi, gdy powrót do zdrowia rozpatrywano w kategoriach remisji klinicznej plus funkcjonalnej.¹⁴

Dane pokazują, że znaczna część osób z rozpoznaniem zaburzenia schizoafektywnego, które otrzymują leczenie, poprawia swój stan. Blisko połowa osób z zaburzeniem schizoafektywnym jest w remisji około pięciu lat po diagnozie, a około 25% funkcjonuje dobrze społecznie przez dwuletnie okresy.¹⁵

Znaczenie leczenia dla rokowania

Kluczowym czynnikiem dla jak najlepszego rokowania w zaburzeniu schizoafektywnym jest otrzymanie odpowiedniego leczenia i przestrzeganie planu terapeutycznego stworzonego dla pacjenta.¹⁶ Choć nie ma gwarancji, ponieważ to złożone zaburzenie jest różne dla każdej osoby i zaangażowanych jest wiele różnych czynników, dla osób żyjących z zaburzeniem schizoafektywnym rokowanie dotyczące poprawy stanu jest dobre.¹⁷

Chociaż obecnie nie ma leku na zaburzenie schizoafektywne, choroba ta może wejść w remisję – okres, w którym objawy nie występują, a funkcjonowanie jest dobre.¹⁸ To podkreśla znaczenie utrzymania leczenia nawet podczas okresów remisji.

Nowe perspektywy w prognozowaniu zaburzenia schizoafektywnego

Sztuczna inteligencja (AI) wykazuje znaczny potencjał w prognozowaniu przebiegu zaburzeń ze spektrum schizofrenii, w tym zaburzenia schizoafektywnego. AI doskonale radzi sobie z opracowywaniem zindywidualizowanych planów prognostycznych, co umożliwia szybką identyfikację progresji choroby, dokładne przewidywanie trajektorii choroby i terminowe dostosowanie strategii leczenia, tym samym poprawiając rokowanie i ułatwiając powrót do zdrowia.¹⁹

Technologie AI znacząco poprawiły dokładność i użyteczność przewidywania ryzyka nawrotu w zaburzeniach psychotycznych. Te postępy nie tylko zapewniają klinicystom bardziej precyzyjne narzędzia predykcyjne, ale także tworzą naukowe podstawy do planowania długoterminowych strategii powrotu do zdrowia dla pacjentów.²⁰

Integracja AI wykracza poza optymalizację leczenia, ułatwiając kompleksowe zrozumienie biopsychospołecznych czynników, które wpływają na indywidualne wyniki leczenia.²¹ AI została również wykorzystana do zbadania złożonych związków między objawami psychologicznymi a cechami metabolicznymi u pacjentów z zaburzeniami ze spektrum schizofrenii.²²

Wnioski końcowe

Rokowanie w zaburzeniu schizoafektywnym jest złożone i zależy od wielu czynników, w tym podtypu zaburzenia, historii choroby, dominujących objawów oraz jakości i ciągłości leczenia. Wyniki długoterminowe wskazują, że pacjenci z zaburzeniem schizoafektywnym mają generalnie lepsze rokowanie niż pacjenci ze schizofrenią, ale gorsze niż osoby z zaburzeniami afektywnymi.²³²⁴

Objawy psychotyczne niezgodne z nastrojem są szczególnie istotnym czynnikiem prognostycznym, związanym z gorszymi wynikami leczenia.²⁵ Niemniej jednak, przy odpowiednim leczeniu i wsparciu, znaczny odsetek pacjentów z zaburzeniem schizoafektywnym może osiągnąć remisję i zadowalający poziom funkcjonowania społecznego.²⁶

Nowe technologie, takie jak sztuczna inteligencja, oferują obiecujące perspektywy w zakresie dokładniejszego prognozowania przebiegu choroby i optymalizacji leczenia, co może w przyszłości poprawić długoterminowe wyniki u pacjentów z zaburzeniem schizoafektywnym.²⁷²⁸

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1 Schizoaffective Disorder: Practice Essentials, Background, Epidemiology
https://emedicine.medscape.com/article/294763-overview
The prognosis for patients with schizoaffective disorder is thought to lie between that of patients with schizophrenia and that of patients with a mood disorder. That is, the prognosis is better than that of schizophrenia alone but worse than that of a mood disorder alone. […] Individuals with the bipolar subtype are thought to have a prognosis similar to those with bipolar type I, whereas the prognosis of people with the depressive subtype is thought to be similar to that of people with schizophrenia. Overall, determination of the prognosis is difficult. […] A poor prognosis in patients with schizoaffective disorder is generally associated with a poor premorbid history, an insidious onset, an absence of precipitating factors, a predominant psychosis, negative symptoms, an early onset, an unremitting course, or having a family member with schizophrenia.
#2 Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders – PubMed
https://pubmed.ncbi.nlm.nih.gov/1897617/
Objective: This research assessed whether the outcome of schizoaffective disorder is more similar to that of schizophrenia or that of affective disorders. […] Outcome for schizoaffective patients 4-5 years after hospitalization differed significantly from that for patients with unipolar depression. However, the differences between schizoaffective and bipolar manic patients were more equivocal. Unlike the patients with bipolar disorder, only a limited number of patients with schizoaffective disorder showed complete recovery in all areas throughout the year preceding the 2-year follow-up and the year preceding the 4- to 5-year follow-up. The differences in outcome between schizoaffective and schizophrenic patients were also mixed. These two groups showed some similarities in outcome, but there were fewer schizoaffective than schizophrenic patients with uniformly poor outcome in all areas.
#3 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms – PubMed
https://pubmed.ncbi.nlm.nih.gov/11059995/
It is unclear whether outcome in schizoaffective disorders is more similar to schizophrenia or affective disorders. […] To provide longitudinal data on clinical course and outcome in schizoaffective disorders versus schizophrenia and affective disorders, and determine whether mood-incongruent psychotic symptoms have negative prognostic implications. […] At all four follow-ups, fewer patients with schizoaffective disorders than with schizophrenia showed uniformly poor outcome. […] Patients with mood-incongruent psychotic symptoms during index hospitalisation showed significantly poorer subsequent outcome (P 0.05). […] Schizoaffective outcome was better than schizophrenic outcome and poorer than outcome for psychotic affective disorders. […] Mood-incongruent psychotic symptoms have negative prognostic implications.
#4 Outcome of schizoaffective disorder at two long-term follow-ups: comparisons with outcome of schizophrenia and affective disorders – PubMed
https://pubmed.ncbi.nlm.nih.gov/1897617/
Overall, schizoaffective patients showed some similarities to both schizophrenic and bipolar manic patients. Schizoaffective patients had somewhat better overall posthospital functioning than patients with schizophrenia, somewhat poorer functioning than bipolar manic patients, and significantly poorer functioning than patients with unipolar depression. The data suggest that when mood-incongruent, schizophrenic-like psychotic symptoms are present in the acute phase, they predict considerable difficulty in outcome, even when affective syndromes are also present, as in schizoaffective disorder. It is likely that schizoaffective disorder is not just a simple variety of affective disorder.
#5 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms | The British Journal of Psychiatry | Cambridge Core
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/tenyear-outcome-patients-with-schizoaffective-disorders-schizophrenia-affective-disorders-and-moodincongruent-psychotic-symptoms/0D2C6F8BEB0297B14D17309C14BA596F
The overall outcome of the patients with schizoaffective disorders was consistently better than that of those with schizophrenia and poorer than that of those with psychotic affective disorders over the 10-year period. […] The linear ranking of the four diagnostic groups in the logistic regression analysis (schizophrenia, schizoaffective disorders, psychotic affective disorders and non-psychotic depression) best accounted for variance in the contribution of diagnosis to poor outcome (P0.01). […] The current data support the hypothesis that patients with a predominance of mood-incongruent psychotic symptoms are more vulnerable to subsequent outcome difficulties in other areas.
#6 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms | The British Journal of Psychiatry | Cambridge Core
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/tenyear-outcome-patients-with-schizoaffective-disorders-schizophrenia-affective-disorders-and-moodincongruent-psychotic-symptoms/0D2C6F8BEB0297B14D17309C14BA596F
The overall outcome of the patients with schizoaffective disorders was consistently better than that of those with schizophrenia and poorer than that of those with psychotic affective disorders over the 10-year period. […] The linear ranking of the four diagnostic groups in the logistic regression analysis (schizophrenia, schizoaffective disorders, psychotic affective disorders and non-psychotic depression) best accounted for variance in the contribution of diagnosis to poor outcome (P0.01). […] The current data support the hypothesis that patients with a predominance of mood-incongruent psychotic symptoms are more vulnerable to subsequent outcome difficulties in other areas.
#7 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms – PubMed
https://pubmed.ncbi.nlm.nih.gov/11059995/
It is unclear whether outcome in schizoaffective disorders is more similar to schizophrenia or affective disorders. […] To provide longitudinal data on clinical course and outcome in schizoaffective disorders versus schizophrenia and affective disorders, and determine whether mood-incongruent psychotic symptoms have negative prognostic implications. […] At all four follow-ups, fewer patients with schizoaffective disorders than with schizophrenia showed uniformly poor outcome. […] Patients with mood-incongruent psychotic symptoms during index hospitalisation showed significantly poorer subsequent outcome (P 0.05). […] Schizoaffective outcome was better than schizophrenic outcome and poorer than outcome for psychotic affective disorders. […] Mood-incongruent psychotic symptoms have negative prognostic implications.
#8 Schizoaffective disorder Information | Mount Sinai – New York
https://www.mountsinai.org/health-library/diseases-conditions/schizoaffective-disorder
People with schizoaffective disorder have a greater chance of going back to their previous level of function than do people with most other psychotic disorders. But long-term treatment is often needed, and results vary from person to person.
#9 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms – PubMed
https://pubmed.ncbi.nlm.nih.gov/11059995/
It is unclear whether outcome in schizoaffective disorders is more similar to schizophrenia or affective disorders. […] To provide longitudinal data on clinical course and outcome in schizoaffective disorders versus schizophrenia and affective disorders, and determine whether mood-incongruent psychotic symptoms have negative prognostic implications. […] At all four follow-ups, fewer patients with schizoaffective disorders than with schizophrenia showed uniformly poor outcome. […] Patients with mood-incongruent psychotic symptoms during index hospitalisation showed significantly poorer subsequent outcome (P 0.05). […] Schizoaffective outcome was better than schizophrenic outcome and poorer than outcome for psychotic affective disorders. […] Mood-incongruent psychotic symptoms have negative prognostic implications.
#10 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms | The British Journal of Psychiatry | Cambridge Core
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/tenyear-outcome-patients-with-schizoaffective-disorders-schizophrenia-affective-disorders-and-moodincongruent-psychotic-symptoms/0D2C6F8BEB0297B14D17309C14BA596F
The overall outcome of the patients with schizoaffective disorders was consistently better than that of those with schizophrenia and poorer than that of those with psychotic affective disorders over the 10-year period. […] The linear ranking of the four diagnostic groups in the logistic regression analysis (schizophrenia, schizoaffective disorders, psychotic affective disorders and non-psychotic depression) best accounted for variance in the contribution of diagnosis to poor outcome (P0.01). […] The current data support the hypothesis that patients with a predominance of mood-incongruent psychotic symptoms are more vulnerable to subsequent outcome difficulties in other areas.
#11 Schizoaffective Disorder: Practice Essentials, Background, Epidemiology
https://emedicine.medscape.com/article/294763-overview
The prognosis for patients with schizoaffective disorder is thought to lie between that of patients with schizophrenia and that of patients with a mood disorder. That is, the prognosis is better than that of schizophrenia alone but worse than that of a mood disorder alone. […] Individuals with the bipolar subtype are thought to have a prognosis similar to those with bipolar type I, whereas the prognosis of people with the depressive subtype is thought to be similar to that of people with schizophrenia. Overall, determination of the prognosis is difficult. […] A poor prognosis in patients with schizoaffective disorder is generally associated with a poor premorbid history, an insidious onset, an absence of precipitating factors, a predominant psychosis, negative symptoms, an early onset, an unremitting course, or having a family member with schizophrenia.
#12 Schizoaffective Disorder: Practice Essentials, Background, Epidemiology
https://emedicine.medscape.com/article/294763-overview
The prognosis for patients with schizoaffective disorder is thought to lie between that of patients with schizophrenia and that of patients with a mood disorder. That is, the prognosis is better than that of schizophrenia alone but worse than that of a mood disorder alone. […] Individuals with the bipolar subtype are thought to have a prognosis similar to those with bipolar type I, whereas the prognosis of people with the depressive subtype is thought to be similar to that of people with schizophrenia. Overall, determination of the prognosis is difficult. […] A poor prognosis in patients with schizoaffective disorder is generally associated with a poor premorbid history, an insidious onset, an absence of precipitating factors, a predominant psychosis, negative symptoms, an early onset, an unremitting course, or having a family member with schizophrenia.
#13 Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia? | Rivista di Psichiatria
https://www.rivistadipsichiatria.it/archivio/1407/articoli/15624/
Long-term outcome has represented one of the main parameters evaluated in an attempt to discriminate between schizoaffective disorders and schizophrenia or mood disorders, unfortunately with contradictory results; indeed, several studies reported outcomes which largely resemble those observed in schizophrenia, whilst others described results similar to those found in affective psychoses, and a certain number of papers described outcome findings placed in an intermediate position between schizophrenic and affective psychoses. […] The findings of the study demonstrate that the proportion of schizoaffective patients meeting criteria for clinical remission was at least ten percentage points higher than that observed among schizophrenic patients, irrespective of the remission criteria adopted.
#14 Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia? | Rivista di Psichiatria
https://www.rivistadipsichiatria.it/archivio/1407/articoli/15624/
In relation to recovery rates, likewise a highly significant difference (more than 16 percentage points) emerged between schizoaffective and schizophrenic patients when recovery was considered in terms of clinical plus functional remission. […] These results seem to indicate that long-term outcome of chronic schizoaffective patients is somewhat better than in schizophrenic patients, both in clinical and functional terms.
#15 Schizoaffective Disorder Prognosis: Will I Ever Get Better? | HealthyPlace
https://www.healthyplace.com/thought-disorders/schizoaffective-disorder-information/schizoaffective-disorder-prognosis-will-i-ever-get-better
The prognosis for schizoaffective disorder can be good, although it varies from person to person. […] Prognosis is the expected outcome for someone living with schizoaffective disorder or any other illness. Its a prediction of how well someone will do over time. If youre living with schizoaffective disorder, you have a good chance of getting better. […] Schizoaffective disorder prognosis is good. People with this psychotic disorder can and often do improve. In fact, a significant portion of people who have been diagnosed with this disorder and are receiving treatment improve. Nearly half of people with schizoaffective disorder are in remission approximately five years after diagnosis and about 25% function well socially for two-year stretches. […] The prognosis for schizoaffective disorder is favorable when compared with other psychotic disorders.
#16 Schizoaffective Disorder Prognosis: Will I Ever Get Better? | HealthyPlace
https://www.healthyplace.com/thought-disorders/schizoaffective-disorder-information/schizoaffective-disorder-prognosis-will-i-ever-get-better
While there isnt a cure for schizoaffective disorder, at least not yet, this illness can go into remission, a period in which symptoms arent present and functioning is good. […] The key for the best possible schizoaffective disorder prognosis is to receive proper treatment and follow the treatment plan created for you. […] While there are no guarantees because this complex disorder is different for everyone and so many different factors are involved, if you are living with schizoaffective disorder, the prognosis is good for getting better.
#17 Schizoaffective Disorder Prognosis: Will I Ever Get Better? | HealthyPlace
https://www.healthyplace.com/thought-disorders/schizoaffective-disorder-information/schizoaffective-disorder-prognosis-will-i-ever-get-better
While there isnt a cure for schizoaffective disorder, at least not yet, this illness can go into remission, a period in which symptoms arent present and functioning is good. […] The key for the best possible schizoaffective disorder prognosis is to receive proper treatment and follow the treatment plan created for you. […] While there are no guarantees because this complex disorder is different for everyone and so many different factors are involved, if you are living with schizoaffective disorder, the prognosis is good for getting better.
#18 Schizoaffective Disorder Prognosis: Will I Ever Get Better? | HealthyPlace
https://www.healthyplace.com/thought-disorders/schizoaffective-disorder-information/schizoaffective-disorder-prognosis-will-i-ever-get-better
While there isnt a cure for schizoaffective disorder, at least not yet, this illness can go into remission, a period in which symptoms arent present and functioning is good. […] The key for the best possible schizoaffective disorder prognosis is to receive proper treatment and follow the treatment plan created for you. […] While there are no guarantees because this complex disorder is different for everyone and so many different factors are involved, if you are living with schizoaffective disorder, the prognosis is good for getting better.
#19 Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? | Schizophrenia
https://www.nature.com/articles/s41537-025-00583-4
This study evaluated the potential of artificial intelligence (AI) in the diagnosis, treatment, and prognostic assessment of schizophrenia (SZ) and explored collaborative directions for AI applications in future medical innovations. […] AI excels in developing individualized prognostic plans, which enables the rapid identification of disease progression, accurate prediction of disease trajectory, and timely adjustment of treatment strategies, thereby improving prognosis and facilitating recovery. […] Despite the immense potential of AI in SZ management, its role as an auxiliary tool must be emphasized, with clinical judgment and compassionate care from healthcare professionals remaining crucial. […] The integration of AI provides an objective and standardized framework for diagnosis and treatment optimization, which overcomes subjectivity in clinical assessments and advances precision medicine across nations, ethnicities, and populations.
#20 Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? | Schizophrenia
https://www.nature.com/articles/s41537-025-00583-4
AI has demonstrated a significant potential in psychological interventions for SZ. […] The integration of AI extends beyond treatment optimization to facilitate a comprehensive understanding of the biopsychosocial factors that influence individual treatment outcomes. […] AI has also been used to explore the complex relationships between psychological symptoms and metabolic characteristics in patients with SZ. […] The application of AI technologies has significantly improved the accuracy and utility of the prediction of relapse risk in SZ. […] These advancements not only provide clinicians with more precise predictive tools but also lay a scientific foundation for planning long-term recovery strategies for patients.
#21 Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? | Schizophrenia
https://www.nature.com/articles/s41537-025-00583-4
AI has demonstrated a significant potential in psychological interventions for SZ. […] The integration of AI extends beyond treatment optimization to facilitate a comprehensive understanding of the biopsychosocial factors that influence individual treatment outcomes. […] AI has also been used to explore the complex relationships between psychological symptoms and metabolic characteristics in patients with SZ. […] The application of AI technologies has significantly improved the accuracy and utility of the prediction of relapse risk in SZ. […] These advancements not only provide clinicians with more precise predictive tools but also lay a scientific foundation for planning long-term recovery strategies for patients.
#22 Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? | Schizophrenia
https://www.nature.com/articles/s41537-025-00583-4
AI has demonstrated a significant potential in psychological interventions for SZ. […] The integration of AI extends beyond treatment optimization to facilitate a comprehensive understanding of the biopsychosocial factors that influence individual treatment outcomes. […] AI has also been used to explore the complex relationships between psychological symptoms and metabolic characteristics in patients with SZ. […] The application of AI technologies has significantly improved the accuracy and utility of the prediction of relapse risk in SZ. […] These advancements not only provide clinicians with more precise predictive tools but also lay a scientific foundation for planning long-term recovery strategies for patients.
#23 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms | The British Journal of Psychiatry | Cambridge Core
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/tenyear-outcome-patients-with-schizoaffective-disorders-schizophrenia-affective-disorders-and-moodincongruent-psychotic-symptoms/0D2C6F8BEB0297B14D17309C14BA596F
The overall outcome of the patients with schizoaffective disorders was consistently better than that of those with schizophrenia and poorer than that of those with psychotic affective disorders over the 10-year period. […] The linear ranking of the four diagnostic groups in the logistic regression analysis (schizophrenia, schizoaffective disorders, psychotic affective disorders and non-psychotic depression) best accounted for variance in the contribution of diagnosis to poor outcome (P0.01). […] The current data support the hypothesis that patients with a predominance of mood-incongruent psychotic symptoms are more vulnerable to subsequent outcome difficulties in other areas.
#24 Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia? | Rivista di Psichiatria
https://www.rivistadipsichiatria.it/archivio/1407/articoli/15624/
In relation to recovery rates, likewise a highly significant difference (more than 16 percentage points) emerged between schizoaffective and schizophrenic patients when recovery was considered in terms of clinical plus functional remission. […] These results seem to indicate that long-term outcome of chronic schizoaffective patients is somewhat better than in schizophrenic patients, both in clinical and functional terms.
#25 Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms – PubMed
https://pubmed.ncbi.nlm.nih.gov/11059995/
It is unclear whether outcome in schizoaffective disorders is more similar to schizophrenia or affective disorders. […] To provide longitudinal data on clinical course and outcome in schizoaffective disorders versus schizophrenia and affective disorders, and determine whether mood-incongruent psychotic symptoms have negative prognostic implications. […] At all four follow-ups, fewer patients with schizoaffective disorders than with schizophrenia showed uniformly poor outcome. […] Patients with mood-incongruent psychotic symptoms during index hospitalisation showed significantly poorer subsequent outcome (P 0.05). […] Schizoaffective outcome was better than schizophrenic outcome and poorer than outcome for psychotic affective disorders. […] Mood-incongruent psychotic symptoms have negative prognostic implications.
#26 Schizoaffective Disorder Prognosis: Will I Ever Get Better? | HealthyPlace
https://www.healthyplace.com/thought-disorders/schizoaffective-disorder-information/schizoaffective-disorder-prognosis-will-i-ever-get-better
The prognosis for schizoaffective disorder can be good, although it varies from person to person. […] Prognosis is the expected outcome for someone living with schizoaffective disorder or any other illness. Its a prediction of how well someone will do over time. If youre living with schizoaffective disorder, you have a good chance of getting better. […] Schizoaffective disorder prognosis is good. People with this psychotic disorder can and often do improve. In fact, a significant portion of people who have been diagnosed with this disorder and are receiving treatment improve. Nearly half of people with schizoaffective disorder are in remission approximately five years after diagnosis and about 25% function well socially for two-year stretches. […] The prognosis for schizoaffective disorder is favorable when compared with other psychotic disorders.
#27 Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? | Schizophrenia
https://www.nature.com/articles/s41537-025-00583-4
This study evaluated the potential of artificial intelligence (AI) in the diagnosis, treatment, and prognostic assessment of schizophrenia (SZ) and explored collaborative directions for AI applications in future medical innovations. […] AI excels in developing individualized prognostic plans, which enables the rapid identification of disease progression, accurate prediction of disease trajectory, and timely adjustment of treatment strategies, thereby improving prognosis and facilitating recovery. […] Despite the immense potential of AI in SZ management, its role as an auxiliary tool must be emphasized, with clinical judgment and compassionate care from healthcare professionals remaining crucial. […] The integration of AI provides an objective and standardized framework for diagnosis and treatment optimization, which overcomes subjectivity in clinical assessments and advances precision medicine across nations, ethnicities, and populations.
#28 Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? | Schizophrenia
https://www.nature.com/articles/s41537-025-00583-4
AI has demonstrated significant advantages in the prediction of SZ. […] Achieving precise and individualized diagnostic capability requires a more comprehensive approach that not only predicts the likelihood of disease onset but also evaluates diverse symptoms, identifies disease subtypes, assesses disease severity, and predicts disease progression trajectories. […] The individualized predictive capabilities of AI represent a paradigm shift in SZ diagnosis. […] AI has demonstrated significant potential in advancing SZ diagnosis and management. […] This capability not only enhances diagnostic precision but also provides a basis for developing individualized treatment strategies. […] The precision of AI in SZ treatment primarily lies in identifying objective biomarkers to predict the effectiveness of therapeutic interventions.